Multiple Sclerosis (MS) Mondays

We are excited to announce the launch of our new weekly series dedicated to Multiple Sclerosis and the people living with it. MS Mondays will be a round up of recent news articles, MS-related events and motivational stories. Because many of UroMed’s patients have MS, we hope this series will be a valuable resource for them as well as anyone who wishes to learn more about the disease. If you would like more information on how UroMed can help those with MS, click here.

Multiple Sclerosis is an autoimmune disease that attacks the central nervous system. Symptoms vary from person to person and can range from mild to severe. Common symptoms include numbness, fatigue, and walking/coordination problems. There are many misconceptions about Multiple Sclerosis, so we’d thought we’d clear some of them up with these facts.

  • More than 400,000 people in the United States have MS.
  • An estimated 2,500,000 around the world have MS.
  • About 45 percent of the people with MS are not severely affected by the disease.
  • Diagnosis of MS is usually between 20 and 40 years of age.
  • MS affects more women than men, with a ratio of 2:1.
  • MS does not significantly affect life span.
  • The course of the disease is unpredictable and no two people will experience the same set of symptoms.
  • There are four types of MS:  relapsing-remitting, secondary-progressive, primary progressive and progressive relapsing.
  • Among young adults, MS is the most common disease of the central nervous system.
  • Fatigue is one of the most common symptoms of MS.
  • MS is not contagious.

 

News for the week of June 16th

As a reminder, these articles are purely informational. You will need to consult your doctor for any medical advice or before beginning any treatment or therapy seen herein.


Study points to easing MS-linked inflammation (The Columbus Dispatch)
“Fatty acids that occur naturally in the brain might reduce inflammation associated with multiple sclerosis, a Stanford University study suggests. The finding might lead to a new approach to treating the disease.”

Hormone Therapy Viable Option for MS Flares (Medpage Today)
“Adrenocorticotropic hormone (ACTH) gel is an effective treatment for multiple sclerosis exacerbations in patients failing methylprednisolone therapy.”

MS sufferer finds Korean physiotherapy has helped control her condition (Daily Record)
A Korean Physiotherapy Clinic based in Edinburgh, Scotland significantly reduced the severity of MS symptoms in one Scottish woman. The woman, who has suffered a number of falls due to the illness, reports that since the treatment she has not fallen once and is able to walk without a cane.

MS liberation treatment offers ‘no measurable change’, study finds (The Hamilton Spectator)
“Patients who underwent the so-called liberation treatment for multiple sclerosis experienced no measurable benefit from the procedure, a study commissioned by the government of Newfoundland and Labrador found.”

Pennsylvania Man Rides Cross-Country for MS (TheDailyReview.com)
“On May 28, Nicholas Lentz … embarked on a bicycle trip across the United States to raise money and awareness for Multiple Sclerosis with the organization “Bike the US for MS”.”

National Multiple Sclerosis Society Launches New “Connections” PSA Campaign (Virtual-Strategy Magazine)
“The National Multiple Sclerosis Society launched a multi-media PSA campaign which reflects the stark reality of what MS does, but more importantly, how the challenges of MS can be overcome by strengthening and growing our connections.”

Teva says MS drug met goals in clinical trial (Bloomberg Business)
Teva Pharmaceutical Industries Ltd. said Thursday that a new version of its multiple sclerosis drug Copaxone met its goals in a late-stage clinical trial.Copaxone is the best-selling multiple sclerosis treatment in the world, and Teva is conducting clinical trials of a more concentrated, long-acting version of the drug.

Jack Osborne Diagnosed with Multiple Sclerosis (MTV)
“Former “Osbournes” star Jack Osbourne has revealed that he’s been diagnosed with multiple sclerosis.”

Upcoming Events

Bike MS:

Colorado’s Ride, Westminster, CO: 6/30

Cruise the Cornfield, Des Moines, IA 6/23

Tour de Farms, Dekalb, IL 6/23

Reeves Northrup Memorial MS Bike to the Bay Ride, Maumee, OH 6/23

Cape Cod Getaway, Boston, MA 6/23

Walk MS: 

Ann Arbor/Dexter Walk MS 6/23

Traverse City Walk MS 6/23

Muck Ruckus MS: 

Ohio Valley 6/30

 

And because it’s Monday, we feel everyone could use a little extra motivation, so here’s today’s
MS Motivational Moment:


About UroMed Catheters
Headquartered in Suwanee, GA [a suburb of Atlanta], UroMed is one of the nation’s leading providers of single-use catheters, urological and disposable medical supplies, including intermittent catheters, closed system catheters, condom catheters, pediatric catheters and continence care products. UroMed is nationally accredited for Medicare reimbursement and most state Medicaid plans, and partners with private health insurance providers and health plans to provide patients with single-use catheters, catheter kits and incontinence products. UroMed also has seven staffed regional offices located in Boston, MA; Columbia, SC; Jacksonville, FL; Dallas, TX; Carlsbad, CA; Knoxville, TN; Richmond, VA; and Baton Rouge, LA; enabling next-day delivery after a customer’s initial medical supply order. For more information, please visit http://www.uromed.com or call 1-800-841-1233.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: